U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Search results

Items: 1 to 100 of 293

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr3:49498433-55348528
GRCh38:
Chr3:49461000-55314500
ABHD14A, ABHD14A-ACY1, ABHD14B, ACTR8, ACY1, ALAS1, AMIGO3, APEH, BAP1, BSN, BSN-DT, C3orf18, CACNA1D, CACNA2D2, CACNA2D3, CACNA2D3-AS1, CAMKV, CDHR4, CHDH, CISH, CYB561D2, DAG1, DCAF1, DCP1A, DNAH1, DOCK3, DUSP7, ESRG, GLT8D1, GLYCTK, GLYCTK-AS1, GMPPB, GNAI2, GNAT1, GNL3, GPR62, GRM2, HEMK1, HYAL1, HYAL2, HYAL3, IFRD2, IL17RB, INKA1, IP6K1, IQCF1, IQCF2, IQCF3, IQCF5, IQCF5-AS1, IQCF6, ITIH1, ITIH3, ITIH4, ITIH4-AS1, LINC00696, LINC02017, LINC02019, LINC02030, LOC101928965, LOC110121103, LOC110121200, LOC110121270, LOC112935947, LOC112935948, LOC112935949, LOC112935950, LOC114004379, LOC114004380, LOC115995511, LOC121009668, LOC121009669, LOC121009670, LOC121009671, LOC121009672, LOC121725145, LOC121725146, LOC122889088, LOC122889089, LOC122889090, LOC122965306, LOC122965307, LOC122965308, LOC122965309, LOC122965310, LOC122965311, LOC126806677, LOC126806678, LOC126806679, LOC126806680, LOC126806681, LOC126806682, LOC126806683, LOC126806684, LOC126806685, LOC126806686, LOC126806687, LOC127898564, LRTM1, LSMEM2, MANF, MAPKAPK3, MIR135A1, MIR4787, MIR5193, MIR566, MIR5787, MIR6872, MIR8064, MIRLET7G, MON1A, MST1, MST1R, MUSTN1, NAA80, NEK4, NISCH, NPRL2, NT5DC2, PARP3, PBRM1, PCBP4, PHF7, POC1A, PPM1M, PRKCD, RAD54L2, RASSF1, RASSF1-AS1, RBM15B, RBM5, RBM5-AS1, RBM6, RFT1, RNF123, RPL29, RRP9, SELENOK, SEMA3B, SEMA3B-AS1, SEMA3F, SEMA3F-AS1, SEMA3G, SFMBT1, SLC38A3, SNORD136, SNORD19, SNORD19B, SNORD19C, SNORD38C, SNORD69, SPCS1, STAB1, STIMATE, STIMATE-MUSTN1, TEX264, TKT, TLR9, TMEM115, TNNC1, TRAIP, TUSC2, TWF2, TWF2-DT, UBA7, UQCC5, WDR82, ZMYND10
See casesPathogenic
(Aug 12, 2011)
criteria provided, single submitter
2.
GRCh37:
Chr3:51431865-55098476
GRCh38:
Chr3:51394434-55064449
See casesLikely pathogenic
(Oct 22, 2013)
no assertion criteria provided
3.
GRCh37:
Chr3:52485105
GRCh38:
Chr3:52451089
TNNC1not providedBenign
(Mar 3, 2015)
criteria provided, single submitter
4.
GRCh37:
Chr3:52485164
GRCh38:
Chr3:52451148
TNNC1not provided, Hypertrophic cardiomyopathy 13, Dilated cardiomyopathy 1Z
Conflicting interpretations of pathogenicity
(Jan 13, 2018)
criteria provided, conflicting interpretations
5.
GRCh37:
Chr3:52485168
GRCh38:
Chr3:52451152
TNNC1not providedBenign
(Mar 3, 2015)
criteria provided, single submitter
6.
GRCh37:
Chr3:52485208
GRCh38:
Chr3:52451192
TNNC1not provided, Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13
Benign/Likely benign
(Jan 13, 2018)
criteria provided, multiple submitters, no conflicts
7.
GRCh37:
Chr3:52485214
GRCh38:
Chr3:52451198
TNNC1not providedBenign
(Mar 3, 2015)
criteria provided, single submitter
8.
GRCh37:
Chr3:52485216
GRCh38:
Chr3:52451200
TNNC1Dilated cardiomyopathy 1Z, Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13,
Hypertrophic cardiomyopathy 13
Uncertain significance
(Aug 20, 2021)
criteria provided, multiple submitters, no conflicts
9.
GRCh37:
Chr3:52485283
GRCh38:
Chr3:52451267
TNNC1not providedUncertain significance
(Nov 4, 2019)
criteria provided, single submitter
10.
GRCh37:
Chr3:52485294
GRCh38:
Chr3:52451278
TNNC1Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13Likely benign
(May 13, 2022)
criteria provided, single submitter
11.
GRCh37:
Chr3:52485297
GRCh38:
Chr3:52451281
TNNC1Hypertrophic cardiomyopathy 13, Dilated cardiomyopathy 1Z, not specified
Likely benign
(Jul 20, 2020)
criteria provided, multiple submitters, no conflicts
12.
GRCh37:
Chr3:52485301
GRCh38:
Chr3:52451285
TNNC1G159Dnot providedLikely pathogenic
(Jan 13, 2020)
criteria provided, single submitter
13.
GRCh37:
Chr3:52485303
GRCh38:
Chr3:52451287
TNNC1Cardiovascular phenotype, Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13
Likely benign
(Aug 10, 2022)
criteria provided, multiple submitters, no conflicts
14.
GRCh37:
Chr3:52485304
GRCh38:
Chr3:52451288
TNNC1K158RDilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13Uncertain significance
(Aug 21, 2021)
criteria provided, single submitter
15.
GRCh37:
Chr3:52485304
GRCh38:
Chr3:52451288
TNNC1K158THypertrophic cardiomyopathy 13, Dilated cardiomyopathy 1ZUncertain significance
(Aug 26, 2021)
criteria provided, single submitter
16.
GRCh37:
Chr3:52485307
GRCh38:
Chr3:52451291
TNNC1M157RDilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13Uncertain significance
(Jul 28, 2021)
criteria provided, single submitter
17.
GRCh37:
Chr3:52485308
GRCh38:
Chr3:52451292
TNNC1M157VDilated cardiomyopathy 1ZUncertain significance
(Oct 18, 2021)
criteria provided, single submitter
18.
GRCh37:
Chr3:52485308
GRCh38:
Chr3:52451292
TNNC1M157LDilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13, Cardiovascular phenotype,
not provided
Uncertain significance
(Sep 29, 2022)
criteria provided, multiple submitters, no conflicts
19.
GRCh37:
Chr3:52485308
GRCh38:
Chr3:52451292
TNNC1M157LPrimary dilated cardiomyopathyUncertain significance
(Sep 29, 2014)
no assertion criteria provided
20.
GRCh37:
Chr3:52485321
GRCh38:
Chr3:52451305
TNNC1E152Dnot provided, Cardiovascular phenotypeUncertain significance
(Nov 15, 2022)
criteria provided, multiple submitters, no conflicts
21.
GRCh37:
Chr3:52485321
GRCh38:
Chr3:52451305
TNNC1not specified, Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13,
Cardiomyopathy
Likely benign
(Sep 11, 2018)
criteria provided, multiple submitters, no conflicts
22.
GRCh37:
Chr3:52485327
GRCh38:
Chr3:52451311
TNNC1Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13Likely benign
(Jun 12, 2020)
criteria provided, single submitter
23.
GRCh37:
Chr3:52485328
GRCh38:
Chr3:52451312
TNNC1not provided, Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13
Conflicting interpretations of pathogenicity
(Sep 2, 2021)
criteria provided, conflicting interpretations
24.
GRCh37:
Chr3:52485336
GRCh38:
Chr3:52451320
TNNC1not specifiedBenign
(Jul 5, 2011)
criteria provided, single submitter
25.
GRCh37:
Chr3:52485340
GRCh38:
Chr3:52451324
TNNC1Hypertrophic cardiomyopathy 13, Dilated cardiomyopathy 1ZLikely benign
(Nov 21, 2021)
criteria provided, single submitter
26.
GRCh37:
Chr3:52485341
GRCh38:
Chr3:52451325
TNNC1Hypertrophic cardiomyopathy 13, Dilated cardiomyopathy 1ZLikely benign
(Jul 5, 2022)
criteria provided, single submitter
27.
GRCh37:
Chr3:52485390
GRCh38:
Chr3:52451374
TNNC1Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13Likely benign
(Jul 1, 2022)
criteria provided, single submitter
28.
GRCh37:
Chr3:52485391
GRCh38:
Chr3:52451375
TNNC1not specifiedUncertain significance
(May 6, 2023)
criteria provided, single submitter
29.
GRCh37:
Chr3:52485392
GRCh38:
Chr3:52451376
TNNC1Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13Likely benign
(Feb 2, 2022)
criteria provided, single submitter
30.
GRCh37:
Chr3:52485400-52485401
GRCh38:
Chr3:52451384-52451385
TNNC1Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13Likely benign
(Dec 14, 2018)
criteria provided, single submitter
31.
GRCh37:
Chr3:52485400
GRCh38:
Chr3:52451384
TNNC1Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13, Cardiomyopathy
Conflicting interpretations of pathogenicity
(Aug 14, 2020)
criteria provided, conflicting interpretations
32.
GRCh37:
Chr3:52485401
GRCh38:
Chr3:52451385
TNNC1Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13, not specified
Conflicting interpretations of pathogenicity
(Jun 20, 2022)
criteria provided, conflicting interpretations
33.
GRCh37:
Chr3:52485401
GRCh38:
Chr3:52451385
TNNC1not specified, Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13
Uncertain significance
(Mar 5, 2022)
criteria provided, multiple submitters, no conflicts
34.
GRCh37:
Chr3:52485404
GRCh38:
Chr3:52451388
TNNC1Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13Uncertain significance
(Nov 12, 2021)
criteria provided, single submitter
35.
GRCh37:
Chr3:52485407
GRCh38:
Chr3:52451391
TNNC1E152KDilated cardiomyopathy 1ZPathogenic
(Apr 30, 2022)
no assertion criteria provided
36.
GRCh37:
Chr3:52485409
GRCh38:
Chr3:52451393
TNNC1D151VDilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13Uncertain significance
(Aug 31, 2021)
criteria provided, single submitter
37.
GRCh37:
Chr3:52485415
GRCh38:
Chr3:52451399
TNNC1D149Gnot providedUncertain significance
(Jul 18, 2023)
criteria provided, single submitter
38.
GRCh37:
Chr3:52485416
GRCh38:
Chr3:52451400
TNNC1D149NDilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13, not specified,
not provided
Uncertain significance
(Apr 15, 2022)
criteria provided, multiple submitters, no conflicts
39.
GRCh37:
Chr3:52485417
GRCh38:
Chr3:52451401
TNNC1Cardiovascular phenotype, Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13
Likely benign
(Jan 17, 2022)
criteria provided, multiple submitters, no conflicts
40.
GRCh37:
Chr3:52485417
GRCh38:
Chr3:52451401
TNNC1Hypertrophic cardiomyopathy 13, Dilated cardiomyopathy 1Z, Cardiovascular phenotype,
Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13
Conflicting interpretations of pathogenicity
(Aug 20, 2022)
criteria provided, conflicting interpretations
41.
GRCh37:
Chr3:52485419
GRCh38:
Chr3:52451403
TNNC1I148VHypertrophic cardiomyopathy 13, Dilated cardiomyopathy 1Z, not specified,
Primary dilated cardiomyopathy
Uncertain significance
(Jun 14, 2022)
criteria provided, multiple submitters, no conflicts
42.
GRCh37:
Chr3:52485421
GRCh38:
Chr3:52451405
TNNC1R147HCardiovascular phenotype, Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13
Uncertain significance
(Oct 17, 2022)
criteria provided, multiple submitters, no conflicts
43.
GRCh37:
Chr3:52485422
GRCh38:
Chr3:52451406
TNNC1R147CCardiomyopathyUncertain significance
(May 9, 2019)
criteria provided, single submitter
44.
GRCh37:
Chr3:52485425
GRCh38:
Chr3:52451409
TNNC1G146RDilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13Uncertain significance
(Jul 29, 2022)
criteria provided, single submitter
45.
GRCh37:
Chr3:52485425
GRCh38:
Chr3:52451409
TNNC1G146CDilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13Uncertain significance
(Jul 15, 2022)
criteria provided, single submitter
46.
GRCh37:
Chr3:52485425
GRCh38:
Chr3:52451409
TNNC1G146SDilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13, Cardiovascular phenotype
Uncertain significance
(Oct 12, 2022)
criteria provided, multiple submitters, no conflicts
47.
GRCh37:
Chr3:52485426
GRCh38:
Chr3:52451410
TNNC1Cardiovascular phenotype, not specified, Dilated cardiomyopathy 1Z,
Hypertrophic cardiomyopathy 13, not provided
Likely benign
(Jan 1, 2023)
criteria provided, multiple submitters, no conflicts
48.
GRCh37:
Chr3:52485426
GRCh38:
Chr3:52451410
TNNC1D145ECardiovascular phenotype, not provided, not specified,
Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13, Cardiomyopathy
Uncertain significance
(Jun 5, 2023)
criteria provided, multiple submitters, no conflicts
49.
GRCh37:
Chr3:52485428
GRCh38:
Chr3:52451412
TNNC1D145HCardiomyopathyUncertain significance
(Jan 11, 2021)
criteria provided, single submitter
50.
GRCh37:
Chr3:52485428
GRCh38:
Chr3:52451412
TNNC1D145NDilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13, not provided
Uncertain significance
(Sep 23, 2022)
criteria provided, multiple submitters, no conflicts
51.
GRCh37:
Chr3:52485429
GRCh38:
Chr3:52451413
TNNC1Cardiovascular phenotype, Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13,
not provided
Likely benign
(Jul 30, 2022)
criteria provided, multiple submitters, no conflicts
52.
GRCh37:
Chr3:52485429-52485431
GRCh38:
Chr3:52451413-52451415
TNNC1N144delDilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13, not specified
Uncertain significance
(Sep 2, 2021)
criteria provided, multiple submitters, no conflicts
53.
GRCh37:
Chr3:52485430
GRCh38:
Chr3:52451414
TNNC1N144Snot specifiedUncertain significance
(Feb 7, 2013)
no assertion criteria provided
54.
GRCh37:
Chr3:52485431
GRCh38:
Chr3:52451415
TNNC1N144DHypertrophic cardiomyopathy 13, Cardiovascular phenotype, not provided,
Cardiomyopathy, Hypertrophic cardiomyopathy 13, Dilated cardiomyopathy 1Z,
Hypertrophic cardiomyopathy
Conflicting interpretations of pathogenicity
(Jun 20, 2023)
criteria provided, conflicting interpretations
55.
GRCh37:
Chr3:52485435
GRCh38:
Chr3:52451419
TNNC1K142NDilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13Uncertain significance
(Aug 31, 2021)
criteria provided, single submitter
56.
GRCh37:
Chr3:52485436-52485437
GRCh38:
Chr3:52451420-52451421
TNNC1K142fsCardiovascular phenotypeUncertain significance
(May 5, 2021)
criteria provided, single submitter
57.
GRCh37:
Chr3:52485442
GRCh38:
Chr3:52451426
TNNC1G140ECardiovascular phenotype, Hypertrophic cardiomyopathy 13, Dilated cardiomyopathy 1Z
Uncertain significance
(Apr 21, 2022)
criteria provided, multiple submitters, no conflicts
58.
GRCh37:
Chr3:52485443
GRCh38:
Chr3:52451427
TNNC1G140RCardiovascular phenotype, Hypertrophic cardiomyopathy 13, Dilated cardiomyopathy 1Z
Uncertain significance
(Apr 24, 2022)
criteria provided, multiple submitters, no conflicts
59.
GRCh37:
Chr3:52485444
GRCh38:
Chr3:52451428
TNNC1Cardiovascular phenotype, Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13,
Cardiomyopathy
Likely benign
(Jan 3, 2021)
criteria provided, multiple submitters, no conflicts
60.
GRCh37:
Chr3:52485445
GRCh38:
Chr3:52451429
TNNC1D139GCardiovascular phenotypeUncertain significance
(Apr 28, 2023)
criteria provided, single submitter
61.
GRCh37:
Chr3:52485445
GRCh38:
Chr3:52451429
TNNC1D139AHypertrophic cardiomyopathy 13, Dilated cardiomyopathy 1ZUncertain significance
(Sep 20, 2022)
criteria provided, single submitter
62.
GRCh37:
Chr3:52485457
GRCh38:
Chr3:52451441
TNNC1E135ADilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13Uncertain significance
(Aug 24, 2021)
criteria provided, single submitter
63.
GRCh37:
Chr3:52485459
GRCh38:
Chr3:52451443
TNNC1Cardiovascular phenotypeLikely benign
(Jan 13, 2021)
criteria provided, single submitter
64.
GRCh37:
Chr3:52485459
GRCh38:
Chr3:52451443
TNNC1E134DCardiovascular phenotype, Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13,
not specified, not provided
Uncertain significance
(Jan 11, 2023)
criteria provided, multiple submitters, no conflicts
65.
GRCh37:
Chr3:52485461
GRCh38:
Chr3:52451445
TNNC1E134KCardiovascular phenotype, Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13,
not provided
Uncertain significance
(Oct 22, 2022)
criteria provided, multiple submitters, no conflicts
66.
GRCh37:
Chr3:52485462
GRCh38:
Chr3:52451446
TNNC1Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13Likely benign
(Jun 13, 2022)
criteria provided, single submitter
67.
GRCh37:
Chr3:52485464
GRCh38:
Chr3:52451448
TNNC1I133VHypertrophic cardiomyopathy 13, Dilated cardiomyopathy 1ZUncertain significance
(Sep 1, 2021)
criteria provided, single submitter
68.
GRCh37:
Chr3:52485465
GRCh38:
Chr3:52451449
TNNC1Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13Likely benign
(Sep 28, 2022)
criteria provided, single submitter
69.
GRCh37:
Chr3:52485465-52485467
GRCh38:
Chr3:52451449-52451451
TNNC1D132delHypertrophic cardiomyopathy 13, Dilated cardiomyopathy 1ZUncertain significance
(Mar 18, 2022)
criteria provided, single submitter
70.
GRCh37:
Chr3:52485467
GRCh38:
Chr3:52451451
TNNC1D132Nnot specifiedUncertain significance
(Jul 6, 2012)
criteria provided, single submitter
71.
GRCh37:
Chr3:52485468
GRCh38:
Chr3:52451452
TNNC1D131EHypertrophic cardiomyopathy 13, Dilated cardiomyopathy 1ZUncertain significance
(Aug 28, 2021)
criteria provided, single submitter
72.
GRCh37:
Chr3:52485468
GRCh38:
Chr3:52451452
TNNC1not provided, Cardiovascular phenotype, Dilated cardiomyopathy 1Z,
Hypertrophic cardiomyopathy 13, Cardiomyopathy
Likely benign
(Oct 28, 2022)
criteria provided, multiple submitters, no conflicts
73.
GRCh37:
Chr3:52485474
GRCh38:
Chr3:52451458
TNNC1Hypertrophic cardiomyopathy 13, Dilated cardiomyopathy 1ZLikely benign
(Feb 21, 2021)
criteria provided, single submitter
74.
GRCh37:
Chr3:52485474
GRCh38:
Chr3:52451458
TNNC1Cardiovascular phenotype, not specified, Dilated cardiomyopathy 1Z,
Hypertrophic cardiomyopathy 13, not provided, Dilated cardiomyopathy 1Z,
Hypertrophic cardiomyopathy 13
Conflicting interpretations of pathogenicity
(Mar 23, 2022)
criteria provided, conflicting interpretations
75.
GRCh37:
Chr3:52485475
GRCh38:
Chr3:52451459
TNNC1T129MCardiovascular phenotype, Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13,
not provided
Uncertain significance
(Jun 10, 2022)
criteria provided, multiple submitters, no conflicts
76.
GRCh37:
Chr3:52485477
GRCh38:
Chr3:52451461
TNNC1Cardiomyopathy, Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13
Likely benign
(Mar 26, 2020)
criteria provided, multiple submitters, no conflicts
77.
GRCh37:
Chr3:52485478
GRCh38:
Chr3:52451462
TNNC1I128TDilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13Uncertain significance
(Sep 2, 2021)
criteria provided, single submitter
78.
GRCh37:
Chr3:52485485
GRCh38:
Chr3:52451469
TNNC1E126KDilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13, not provided,
Cardiomyopathy
Uncertain significance
(Aug 20, 2022)
criteria provided, multiple submitters, no conflicts
79.
GRCh37:
Chr3:52485486
GRCh38:
Chr3:52451470
TNNC1Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13, Cardiovascular phenotype
Likely benign
(Oct 18, 2022)
criteria provided, multiple submitters, no conflicts
80.
GRCh37:
Chr3:52485486
GRCh38:
Chr3:52451470
TNNC1Hypertrophic cardiomyopathy 13, Dilated cardiomyopathy 1ZLikely benign
(May 13, 2021)
criteria provided, single submitter
81.
GRCh37:
Chr3:52485489
GRCh38:
Chr3:52451473
TNNC1Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13Likely benign
(Jan 13, 2020)
criteria provided, single submitter
82.
GRCh37:
Chr3:52485491
GRCh38:
Chr3:52451475
TNNC1T124PHypertrophic cardiomyopathy 13, Dilated cardiomyopathy 1ZUncertain significance
(Sep 11, 2022)
criteria provided, single submitter
83.
GRCh37:
Chr3:52485497-52485499
GRCh38:
Chr3:52451481-52451483
TNNC1Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13Uncertain significance
(Jan 1, 2021)
criteria provided, single submitter
84.
GRCh37:
Chr3:52485497-52485498
GRCh38:
Chr3:52451481-52451482
TNNC1Q122fsHypertrophic cardiomyopathy 13, Dilated cardiomyopathy 1ZUncertain significance
(Jun 26, 2021)
criteria provided, single submitter
85.
GRCh37:
Chr3:52485498
GRCh38:
Chr3:52451482
TNNC1Cardiovascular phenotypeLikely benign
(Jan 10, 2020)
criteria provided, single submitter
86.
GRCh37:
Chr3:52485505
GRCh38:
Chr3:52451489
TNNC1I119THypertrophic cardiomyopathy 13, Dilated cardiomyopathy 1ZUncertain significance
(Jun 10, 2022)
criteria provided, multiple submitters, no conflicts
87.
GRCh37:
Chr3:52485506
GRCh38:
Chr3:52451490
TNNC1I119VHypertrophic cardiomyopathy 13, Dilated cardiomyopathy 1ZUncertain significance
(Aug 28, 2021)
criteria provided, single submitter
88.
GRCh37:
Chr3:52485507
GRCh38:
Chr3:52451491
TNNC1K118NHypertrophic cardiomyopathy 13, Dilated cardiomyopathy 1ZUncertain significance
(Aug 14, 2021)
criteria provided, single submitter
89.
GRCh37:
Chr3:52485507
GRCh38:
Chr3:52451491
TNNC1Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13Likely benign
(Jan 29, 2018)
criteria provided, single submitter
90.
GRCh37:
Chr3:52485510
GRCh38:
Chr3:52451494
TNNC1Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13Likely benign
(Jun 14, 2022)
criteria provided, single submitter
91.
GRCh37:
Chr3:52485513
GRCh38:
Chr3:52451497
TNNC1E116DDilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13Uncertain significance
(Sep 2, 2021)
criteria provided, single submitter
92.
GRCh37:
Chr3:52485520
GRCh38:
Chr3:52451504
TNNC1L114RDilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13, Cardiovascular phenotype
Uncertain significance
(Sep 19, 2022)
criteria provided, multiple submitters, no conflicts
93.
GRCh37:
Chr3:52485522
GRCh38:
Chr3:52451506
TNNC1D113EHypertrophic cardiomyopathy 13, Dilated cardiomyopathy 1ZUncertain significance
(Oct 23, 2022)
criteria provided, single submitter
94.
GRCh37:
Chr3:52485523-52485539
GRCh38:
Chr3:52451507-52451523
TNNC1A108fsHypertrophic cardiomyopathy 13, Dilated cardiomyopathy 1ZUncertain significance
(Jun 19, 2022)
criteria provided, single submitter
95.
GRCh37:
Chr3:52485524
GRCh38:
Chr3:52451508
TNNC1D113fsDilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13Uncertain significance
(Feb 5, 2020)
criteria provided, single submitter
96.
GRCh37:
Chr3:52485524
GRCh38:
Chr3:52451508
TNNC1D113Nnot provided, Hypertrophic cardiomyopathy 13, Dilated cardiomyopathy 1Z
Uncertain significance
(Mar 19, 2022)
criteria provided, multiple submitters, no conflicts
97.
GRCh37:
Chr3:52485525
GRCh38:
Chr3:52451509
TNNC1I112MDilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13Uncertain significance
(Aug 27, 2021)
criteria provided, single submitter
98.
GRCh37:
Chr3:52485525
GRCh38:
Chr3:52451509
TNNC1Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13Likely benign
(Apr 8, 2022)
criteria provided, single submitter
99.
GRCh37:
Chr3:52485527
GRCh38:
Chr3:52451511
TNNC1I112VHypertrophic cardiomyopathy 13, Dilated cardiomyopathy 1Z, not provided
Uncertain significance
(Aug 4, 2021)
criteria provided, multiple submitters, no conflicts
100.
GRCh37:
Chr3:52485533
GRCh38:
Chr3:52451517
TNNC1G110CDilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13Uncertain significance
(Aug 24, 2021)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination